Dr Laura Brady

Laura Brady (PhD) is Chief Executive Officer of the Irish Platform for Patient Organisations, Science & Industry (IPPOSI), a multi-stakeholder platform aimed at advancing person-centred healthcare, research and innovation in Ireland. Prior to joining IPPOSI, Laura was Digital Health Innovation Lead at the FutureNeuro Research Ireland Centre, where she led the implementation of a data and digital health strategy and ensured PPI was embedded throughout the Centre’s digital health research programme. Previously, she was Head of Research at Fighting Blindness, where she led the organisation’s research strategy, strengthened PPI capacity among both researchers and patients, and generated evidence that contributed to the reimbursement approval of Ireland’s first gene therapy for a rare retinal disease. Through her role at IPPOSI, Laura contributes to the PPI Ignite Network as a national partner and collaborates with Queen’s University Belfast, South East Technological University (SETU) and Technological University Dublin (TU Dublin) as local partners.